• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种选择用于检验生物等效性的合适统计方法的方法。

An approach to select the appropriate statistical method for testing bioequivalence.

作者信息

Steyn H S, Koeleman H A, Gouws E, Ritschel W A

机构信息

Statistical Consultation Service, Potchefstroom University for Christian Higher Education, South Africa.

出版信息

Int J Clin Pharmacol Ther Toxicol. 1991 Apr;29(4):156-60.

PMID:1822089
Abstract

Since most bioavailability studies are usually done with only a limited number of volunteers (usually 10-30), the statistical properties of the calculated bioavailability parameters are not well defined. The established statistical methods to test bioequivalence are usually based on either the assumption of normality or a symmetrical distribution. However, the decision of which method to apply, depends primarily on the distributional assumption of the data. In this study, an approach is followed where the small data base of a limited number of volunteers is expanded by adding pseudo-volunteers by "bootstrap" simulations. From such a larger data base it is easier to determine the statistical distributional properties of bioavailability parameters, which in its turn leads to the identification of an appropriate statistical method. With more certainty on which statistical method to apply, the original data can be used more effectively in testing for bioequivalence. In this paper, comparisons are made between the distributions of bioavailability parameters of an actual 60-volunteer study and those of two simulated data sets. Each such data set contained a random sample of 10 volunteers each (from the 60 volunteers), together with 50 pseudo-volunteers. These 50 volunteers were simulated from the random sample of 10 real volunteers. Good correspondences were obtained when comparing these two data sets with the original data, which indicated the validity to use this approach in bioavailability studies where a small number of volunteers had been used. This method proved useful to define the distributional properties for a relative small number of parameter-values available.

摘要

由于大多数生物利用度研究通常仅在有限数量的志愿者(通常为10 - 30名)身上进行,因此计算得出的生物利用度参数的统计特性并不明确。用于测试生物等效性的既定统计方法通常基于正态性假设或对称分布假设。然而,应用哪种方法的决策主要取决于数据的分布假设。在本研究中,采用了一种方法,即通过“自助法”模拟添加虚拟志愿者来扩展有限数量志愿者的小数据库。从这样一个更大的数据库中更容易确定生物利用度参数的统计分布特性,进而有助于确定合适的统计方法。在更确定应用哪种统计方法的情况下,原始数据可以更有效地用于生物等效性测试。在本文中,对一项实际的60名志愿者研究的生物利用度参数分布与两个模拟数据集的分布进行了比较。每个这样的数据集包含10名志愿者的随机样本(从60名志愿者中选取)以及50名虚拟志愿者。这50名志愿者是从10名真实志愿者的随机样本中模拟出来的。将这两个数据集与原始数据进行比较时获得了良好的对应关系,这表明在使用少量志愿者的生物利用度研究中使用这种方法是有效的。该方法被证明对于定义相对少量可用参数值的分布特性很有用。

相似文献

1
An approach to select the appropriate statistical method for testing bioequivalence.一种选择用于检验生物等效性的合适统计方法的方法。
Int J Clin Pharmacol Ther Toxicol. 1991 Apr;29(4):156-60.
2
Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.仿制阿奇霉素胶囊与品牌阿奇霉素胶囊的生物利用度和药代动力学比较:一项在泰国健康男性志愿者中进行的随机、双盲、双向交叉试验。
Clin Ther. 2007 Apr;29(4):703-10. doi: 10.1016/j.clinthera.2007.04.010.
3
A new approach for outliers in a bioavailability/bioequivalence study.生物利用度/生物等效性研究中异常值的一种新处理方法。
J Biopharm Stat. 2007;17(3):393-405. doi: 10.1080/10543400701199528.
4
Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.人体志愿者中地瑞茶碱 - 地高辛生物(不)等效性评估。II. 兔作为定性动物模型的评价
Methods Find Exp Clin Pharmacol. 1986 May;8(5):303-7.
5
Evaluation of bioavailability by different methods.
Methods Find Exp Clin Pharmacol. 1985 Aug;7(8):439-49.
6
On TIER method for assessment of individual bioequivalence.用于评估个体生物等效性的TIER方法。
J Biopharm Stat. 1997 Mar;7(1):63-85. doi: 10.1080/10543409708835170.
7
Statistical aspects of comparative bioavailability trials.生物利用度比较试验的统计学方面
Biometrics. 1979 Mar;35(1):273-80.
8
Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.500毫克克拉霉素缓释片两种制剂在空腹和进食条件下的生物等效性评估:一项在健康约旦男性志愿者中进行的单剂量、随机、开放标签、两周期、双向交叉研究。
Clin Ther. 2008 Oct;30(10):1831-43. doi: 10.1016/j.clinthera.2008.10.010.
9
[The bioequivalence of metoclopramide in two tablet formulations].[两种片剂剂型中甲氧氯普胺的生物等效性]
Arzneimittelforschung. 1995 Mar;45(3):304-6.
10
Bayesian modeling of multivariate average bioequivalence.多变量平均生物等效性的贝叶斯建模
Stat Med. 2008 Jun 15;27(13):2402-19. doi: 10.1002/sim.3160.

引用本文的文献

1
Comparison of parametric and bootstrap method in bioequivalence test.参数法和自举法在生物等效性检验中的比较。
Korean J Physiol Pharmacol. 2009 Oct;13(5):367-71. doi: 10.4196/kjpp.2009.13.5.367. Epub 2009 Oct 31.